MVM
Medicxi Ventures Management Portfolio holdings
AUM
$427M
This Quarter Return
-6.74%
1 Year Return
+42.94%
3 Year Return
+262.94%
5 Year Return
+109.92%
10 Year Return
–
AUM
$313M
AUM Growth
+$313M
(-12%)
Cap. Flow
-$13.5M
Cap. Flow
% of AUM
-4.32%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
1
Closed
–
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNTA
1
Centessa Pharmaceuticals
CNTA
$2.25B
| $129M | 41.24% | 19,963,157 | – | – |
|
2
Vaxcyte
PCVX
$4B
| $53.5M | 17.09% | 1,049,893 -265,542 | -20% | -$13.5M |
|
3
Phathom Pharmaceuticals
PHAT
$864M
| $39M | 12.45% | 3,760,869 | – | – |
|
4
Merus
MRUS
$4.98B
| $37.7M | 12.05% | 1,600,000 | – | – |
|
5
Aura Biosciences
AURA
$389M
| $27.3M | 8.71% | 3,039,892 | – | – |
|
6
NewAmsterdam Pharma
NAMS
$2.71B
| $26.5M | 8.47% | 2,869,565 | – | – |
|